1. Medtech Insight
  2. >>Geography
  3. >>Europe
  4. >>United Kingdom

With A New Director Elect, NICE Is On A Mission To Elevate Medtech

 
• By Ashley Yeo

A refreshed NICE, soon to get a new medtech director, has set out a series of priorities that show an intent to bring medtech closer to the center of its activities.

alamy

The National Institute for Health and Care Excellence (NICE) – the health technology assessment body for England and Wales – has appointed Mark Chapman as medtech director, with effect from 30 May 2022. The appointment was announced by Jeanette Kusel, the institute’s acting interim director for medtech and digital, during the Association of British HealthTech Industries’ (ABHI) 28 April conference, “Changes and challenges for the NHS.”

For the past eight years, Chapman has been director for health economics and commissioning at Medtronic plc. He has had input into NICE committees and taken part in NICE’s...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from United Kingdom

More from Europe

Plans For Specific EU Orphan And Pediatric Device Expert Panel Need To Go Further

 
• By Amanda Maxwell

Moves are at last underway for a more specific focus on orphan and pediatric devices. They are a start; but experts are calling for more to support this sector.

MORE Details On MHRA’s Online Platform For Post Market Surveillance

 
• By Ashley Yeo

Post-market surveillance regulations for medtech system users in Great Britain coming into force on 16 June will make new data requirements under new compliance deadlines.

23andMe Purchase Will Let Regeneron Scale Drug Development

 
• By Alaric DeArment

The consumer genomics firm will operate as a subsidiary, while Regeneron plans to leverage its database for drug discovery and trial design efforts.